Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone Therapy for Adolescent Irregular Menstruation
NCT02486757Phase 1Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of estradiol and progesterone in menstrual disorder, sponsored by Massachusetts General Hospital. Primary endpoint: Ovulation in Cycle 2. Started Apr 2015; status: completed.
02
Drugs
estradiolprogesterone
03
Conditions
menstrual disorder
Beyond the preview
Go deeper on NCT02486757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486757.